Varian acts in Europe, China
Varian Medical Systems announced during the RSNA meeting it had acquired the assets of MRW, a reloader and distributor of medical x-ray tubes in Germany. Reloaders put new cores into burned out x-ray tubes and reseal them with oil-filled housings. The
Varian Medical Systems announced during the RSNA meeting it had acquired the assets of MRW, a reloader and distributor of medical x-ray tubes in Germany. Reloaders put new cores into burned out x-ray tubes and reseal them with oil-filled housings. The newly acquired assets will become part of Varian's x-ray products business based in Salt Lake City. MRW will assemble replacement tubes in Düsseldorf, Germany, from components produced at Varian's manufacturing facility in Salt Lake City. The company expects to leverage the acquisition to expand its x-ray business in the European Union by stocking inventory and maintaining a team of technical and marketing specialists there.
In a separate deal, Varian Medical agreed to supply hospitals and clinics in China with replacement tubes for Toshiba CT scanners. Under the cooperative agreement announced at the RSNA meeting with Toshiba Medical and its joint venture partner Sanko Medical Systems, Varian has authorized an x-ray tube service center that will serve China. Sanko Medical Systems in Beijing will operate the new tube facility. Toshiba, Sanko, and Varian plan to expand the relationship to eventually include the full range of Varian's nonproprietary x-ray tube products.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
